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Abstract
There are between 8 and 11 million cases of America Human Trypanosomiasis,
commonly known as Chagas disease, in Latin America. Chagas is endemic in southern
Peru, especially the Arequipa region, where it has expanded from poor, rural areas to
periurban communities. This paper summarizes the findings of four studies in
periurban Arequipa: on determinants of disease-vector infestation; on prevalence,
spatial patterns, and risk factors of Chagas; on links between migration, settlement
patterns, and disease-vector infestation; and on the relationship between discordant
test results and spatially clustered transmission hotspots. These studies identified two
risk factors associated with the disease: population dynamics and the urbanization of
poverty. Understanding the disease within this new urban context will allow for
improved public health prevention efforts and policy initiatives.
Discovered in 1909 by Brazilian physician Carlos Chagas, American Human
Trypanosomiasis is a chronic and potentially life-threatening illness found throughout
Latin America (Moncayo, 2003). Indeed, it is estimated that there are between 8 and
11 million cases in Mexico and Central and South America (Centers for Disease
Control [CDC], 2009). Chagas disease, as it is most commonly known, is endemic in
southern Peru, especially in the region of Arequipa. Once thought to be limited to
poor, rural areas, the disease is now appearing in the periurban communities that
surround Arequipa City, the capital of the region (Cornejo del Carpio, 2003).

Journal of International and Global Studies
2
Understanding the urbanization of Chagas disease will allow public health and
medical professionals to better combat the further transmission of the disease.
After providing an overview of Chagas and introducing the scope of the disease in
Latin America, this paper will summarize the findings of four recent studies
conducted in periurban districts in Arequipa. Ultimately, this paper seeks to identify
the risk factors associated with Chagas infection in Arequipa’s periurban
communities.
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What is Chagas Disease?
Chagas, like other neglected tropical diseases, is generally found among
marginalized populations in poor countries. Indeed, individuals infected with the disease
tend to earn lower incomes, suffer from chronic malnourishment, have lower educational
levels, and live in poor-quality housing (Franco-Paredes et al., 2007). The disease not
only stems from poverty, but also perpetuates the so-called “cycle of poverty.” Since
Chagas symptoms manifest themselves in the most economically productive members of
the population, the disease renders many unable to sustain a livelihood (Moncayo, 2003;
Franco-Paredes et al., 2007; Tarleton, Reithinger, Urbina, Kitron, & Gürtler, 2007).
According to the World Health Organization, Chagas disease causes more
morbidity and mortality than any other parasitic disease in the Western Hemisphere
(World Health Organization [WHO], 2002). Up to 11 million individuals in Latin
America are infected with the disease, and it is estimated that the disease accounts for a
loss of 670,000 disability-adjusted life years annually (WHO, 2004; CDC, 2009).
Moreover, the Inter-American Development Bank calculated that the economic burden of
Chagas was five to ten times higher than malaria (Inter-American Development Bank
[IADB], 2002). Though historically endemic to rural areas, within the past two decades,
Chagas disease has become increasingly urbanized and is now found in cities throughout
the Americas (WHO, 2002; Bastien, 1998).
Transmission
Chagas disease primarily occurs through vector-borne transmission by various
species of triatomine bugs. In the transmission process, the protozoan parasite
Trypanosoma cruzi (T. cruzi) is transferred to a human or other mammal through the
feces of the triatomine insect vector. Typically, the feces enter though the insect bite
wound or through the host’s mucus membranes (Kirchoff, Weiss, Wittner, & Tanowitz,
2004). Known as the “kissing bug” because it usually bites the host’s face, the triatomine
insect is the main Chagas vector in the Southern Cone of South America (Bastien, 1998;
CDC, 2009; Dias, Silveira, & Schofield, 2002). Furthermore, it is highly synanthropic, or
ecologically associated with humans (Zeldon & Rabinovich, 1981; Cohen & Gurtler,
2001).
Another transmission route for Chagas disease is by blood transmission. Until
recently, few countries screened donor blood for the T. cruzi parasite, and infectivity risk
for individuals who received contaminated blood was estimated to be as high as 20%
(WHO, 2002). Ten South American and three Central American countries now screen all
blood donations (WHO, 2002). Transfusionial transmission presents a challenge to both
endemic and non-endemic countries. Chagas-infected migrants unknowingly transport
the disease to Europe and the United States, where blood was not routinely screened for
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T. cruzi until 2007 (WHO, 2002; Bern, Montgomery, Katz, Caglioti & Stramer, 2008;
Piron et al., 2008; Bastien, 1998).
Chagas may also be transmitted congenitally—from mother to fetus—or through
organ transplantation, as well as through the consumption of T. cruzi-contaminated foods
or liquids (Benchimol Barbosa, 2006; Gurtler, Segura, & Cohen, 2003; Dorn et al., 2007;
Tarleton et al., 2007). These transmission routes, however, are less common.
Symptoms and Signs
Though the severity and course of the disease affect individuals differently, there
are generally two stages of Chagas disease, acute and chronic, both of which can be
dangerously asymptomatic. Indeed, most cases never come to the attention of a
physician. Persisting for the first few weeks or months of infection, symptoms in the
acute stage include body aches, loss of appetite, fever, fatigue, headache, rash, diarrhea,
and vomiting. The liver, spleen, and glands may also become enlarged. The most
identifiable sign of acute Chagas infection, however, is Romaña’s sign, in which the
eyelid and face swell. While most symptoms are resolved over time—acute Chagas
disease is rarely fatal to otherwise healthy adults and children—the infection will persist
if left untreated (CDC, 2009). Chronic Chagas, thus, ensues.
During the chronic stage of Chagas, the disease remains asymptomatic, though it
is relatively common for individuals to develop cardiac and digestive problems. Indeed,
between 20 to 30% of Chagas-infected individuals suffer from such diseases as
cardiomyopathy (enlarged heart), arrhythmia (varied heart rate or rhythm), cardiac arrest,
megacolon (enlarged colon) and megaesophagus (enlarged esophagus) (Bastien, 1998;
CDC, 2009). Chronic Chagas disease is particularly dangerous because many individuals
are unaware of the infection until major complications occur. Population screenings are
therefore important for early detection and treatment (Bern, Montgomery, & Herwaldt,
2007).
Treatment
Test results for Chagas disease are sometimes inconclusive due to discordant
testing outcomes. Confirmation of the disease requires that an individual test positive on
two or more serological tests, which generally include a screening and confirmatory test
(WHO Expert Committee, 2000; Bern et al., 2007). An individual, for example, may test
positive for Chagas during the initial screening but negative in the confirmatory testing.
In such a case, current public health policy usually considers the results to signal a false
positive, and the individual is not typically offered treatment (Leiby et al., 2000). The
lack of optimum diagnostic tests complicates the epidemiological understanding of the
disease, as well as its clinical management.
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There are two treatment options for Chagas disease: parasitic and symptomatic
treatment. Parasitic treatment involves the actual killing of the T. cruzi parasite and is
generally most effective after initial infection and during the acute stage (CDC, 2009).
Nevertheless, anti-parasitic treatment has been found to be efficacious in infected
children in the intermediate stages of the disease and has even been shown to slow
disease progression in adults (Andrade et al., 1996; Viotti et al., 2006). However, antiparasitic treatment does “lack optimal efficacy” (WHO, 2000). Furthermore, the
treatment is known to have severe side effects, and doctors consequently limit its use.
Anti-parasitic drugs, moreover, are expensive for many Chagas-infected individuals,
though many governments do subsidize the cost of treatment (Ministerio de Salud del
Perú [MINSA], 1998; WHO, 2002; Levy et al., 2009).
Symptomatic treatment for chronic Chagas requires long-term care to manage the
cardiac and digestive ailments that develop in later stages of the disease. Such treatment,
however, is often expensive and requires medical infrastructure that may not exist in the
country or may be inaccessible to the poor (WHO, 2002).
International Initiatives to Combat Chagas
Several Chagas-endemic countries in Latin America have combined efforts to
combat the disease. Together with the Pan American Health Organization, the Ministries
of Health from Argentina, Bolivia, Brazil, Chile, Paraguay, and Uruguay launched the
Southern Cone Initiative to Control/Eliminate Chagas (INCOSUR) in 1991. Peru later
joined the Initiative. INCOSUR aimed to coordinate triatomine elimination campaigns
through clearly defined objectives and quality control (Schofield & Dias, 1999; Silveira,
Umezawa, & Luquetti, 2001; Dias, Silveira, & Schofield, 2002). Each country finances
and manages its Chagas-control campaigns, and meet annually to share information,
methods, and lessons learned (Skolnik, 2008). Many of the anti-Chagas programs to date
include systematic and repeated sprayings of insecticide, as well as rebuilding or
improving homes with materials inhospitable to triatomine insects (Silveira et al., 2001).
In general, INCOSUR has been successful. Indeed, between 1992 and 2001, 2.5
million homes were sprayed, which most likely contributed to the halting of disease
transmission in Chile and Uruguay, as well as parts of Argentina, Brazil, and Paraguay.
Additionally, the number of new cases in South America fell from 700,000 in 1983 to
200,000 in 2000, and the number of annual deaths was halved to 22,000 (Skolnik, 2008).
Transfusional and congenital transmissions have also declined due respectively to donor
screening at blood banks and early detection programs (Silveira et al., 2001; Skolnik,
2008).
Chagas Disease in Peru
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It is estimated that 192,000 Peruvians are infected with Chagas disease, which is
endemic to southern Peru and to areas in the north of the country (PAHO, 2006; Remme
et al., 2006). The northern regions of Cajamarca, San Martin, Ucayali, and Amazonas are
home to 13 triatomine species that can be infected by the T. cruzi parasite (CubaCuba,
Abad-Franch, Roldan Rodriguez, Vargas Vasquez, Pollack Velasquez, & Miles, 2002).
These species are domiciliary, peridomiciliary, and wild, and they present an interesting
opportunity for research into the eco-epidemiology of villages in the Amazon Basin. Due
to a lack of current epidemiological and entomological data, however, these regions are
not included in control programs (CubaCuba et al., 2002). This paper will focus only on
the Chagas-endemic areas in southern Peru.
Approximately 80% of all cases in the south of the country occur within the
region of Arequipa, though the disease has been reported in Tacna, Moquegua,
Ayacucho, Ica, and Apurimac. Triatomine infestans, the sole vector of Chagas disease in
southern Peru, thrive between 10 to 3,075 meters above sea level and are found between
13.0 to 19.0 degrees latitude south, rendering the area a perfect environment for
infestation (Cornejo del Carpio, 2003).
Compared to individuals in Bolivia, another Chagas-endemic country, Peruvians
have relatively poor immunological response to infection. Indeed, when two types of
rapid tests were performed on specimens from the two countries, the Bolivian samples
were 87.5% sensitive with Stat-Pak and 90.7% sensitive with Trypanosoma Detect, both
with 100% specificity. Peruvian specimens, however, showed a much lower sensitivity:
26.6% to 33.0% with Stat-Pak, and 54.3% to 55.2% with Trypanosoma. Both also had
specificities below 98%. These results may be caused by the difference in parasite
heterogeneity. Moreover, they could signal a major difference in immunologic response
by location (Verani et al., 2009).
The Peruvian Ministry of Health (MOH) has made concerted efforts to interrupt
Chagas transmission. In 2002, the MOH launched the Project to Control Chagas Disease
or Proyecto de Control de la Enfermedad de Chagas, the objective of which was to use a
spray-based approach to eliminate the triatomine vectors in 18,000 houses in Arequipa
(MINSA, 2005). Unlike other INCOSUR-affiliated vector-control campaigns, which
primarily targeted rural areas, the MOH initiative was concentrated in periuban districts
(Levy et al., 2009). A similar model has been adopted in Chagas-endemic areas in
northern Peru, and the MOH is receiving technical and financial support from the Pan
American Health Organization and the Canadian International Development Agency
(MINSA, 2005).
A Multi-disciplinary Overview of Chagas in Periurban Southern Peru
In southern Peru, as the disease moves into previously Chagas-free periurban and
urban areas, the epidemiology and ecology are adapting to the new context and are not
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yet entirely understood. The following four studies were carried out in various
communities of periurban Arequipa, Peru, and are mapped in Figure 1. Though distinct in
their methodologies and themes, each contributes key information to understanding the
dynamics and risk factors of Chagas disease in a periurban setting. Before reviewing the
studies, it is important to understand the context in which they were conducted.
Arequipa
Located in southern Peru, the department of Arequipa borders the departments of
Puno, Ica, Ayacucho, Moquegua, Apurímac, and Cuzco, as well as the Pacific Ocean (see
Figure 1). Between 2001 and 2008, the region’s economy grew an average of 7.8% a
year, and the region has a comparatively low rate of poverty—23.8%—to the national
average of 36.3% (Instituto Nacional de Estadística e Informática [INEI], 2002-2008;
INEI, 2007). Accordingly, Arequipa enjoys relatively high human development
indicators compared to the rest of the country. Life expectancy for men and women in the
department is 73.0 and 77.8 years, respectively, while national life expectancy is 70.5 for
men and 73.5 for women. At 17.3 deaths per 1,000 births, infant mortality is lower than
the national rate of 18.5 (INEI, 2007). Furthermore, a little more than half—53.2%—of
the population has some form of health insurance, compared to only 41.8% nationally
(INEI, 2008).
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Figure 1. Map of the city of Arequipa and surrounding communities and study sites.
Eight provinces—Arequipa, Camaná, Caravelí, Castilla, Caylloma, Condesuyos,
Islay, and La Unión—constitute the department of Arequipa. The region’s population is
largely urban with 71.3% of Arequipeños living in Arequipa City, the capital. Most
commonly known as “Arequipa,” the regional capital is Peru’s second-largest city with a
metropolitan area of 904,931 residents organized into 29 districts (INEI, 2009). The city
sits at the foot of an inactive volcano in the southwestern Andes and has an altitude of
2,328 meters above sea level (INEI, 2008). The most populated districts of the city form
the metropolitan area, and some urban zones have population densities of up to 30,000
residents per km2. Between 2000 and 2004, the metropolitan area experienced a total of
2.4% population growth, and by 2015, Arequipa is expected to be home to 1,061,582
people. Two of the metropolitan districts, Cayma and Jacobo D. Hunter, are predicted to
grow at an annual rate of 11.2% and 10.0%, respectively (Swiss Contact, 2005). A
subsequent section of this paper will reveal that a high population density is a risk factor
for Chagas disease.
Arequipa has always been an industrial, agricultural, and commercial hub, as well
as an administrative center. Consequently, the city has been attractive to rural-to-urban
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migrants seeking better economic opportunities. Since the 1950s, Arequipa has been the
“focal point” of migration in southern Peru. In the past, rural-to-urban migrants typically
migrated first to the center of the city. However, due to high rents, overcrowding, and a
desire for a place of their own, more recent migrants moved to the peripheral agricultural
lands and founded squatter settlements in sparsely populated areas. Indeed, by 1956,
there were already 12 shantytowns, or pueblos jóvenes, with 13,000 inhabitants sprouting
around the city’s periphery (Schuurman, 1986). More formal settlement dates, however,
range from 1970 to 1995, though these shantytowns continue to be established (Bayer et
al., 2009).
Once established, these pueblos jóvenes began to serve as reception points for
new migrants, especially those with ties to friends or family already residing in the area,
as people tend to concentrate according to similar regional backgrounds (Schuurman,
1986). Though Chagas has typically been characterized as a “rural disease,” transmission
cycles of disease are well established in some urban pueblos jóvenes on the outskirts of
urban Arequipa (Levy et al., 2006; Bowman et al., 2008).
Periurban T. cruzi-infected Triatoma Infestans in Arequipa
Chagas has traditionally been characterized as a rural disease, and as a result,
there is little epidemiological information about disease transmission in urban areas. Levy
et al. (2006) thus sought to fill this knowledge gap by conducting a study to identify
determinants of triatomine infestation and population density in Guadalupe, a district in
periurban Arequipa. Additionally, in order to examine the risk for potential Chagas
transmission by these vectors in the community, the authors examined triatomines for T.
cruzi parasites (Levy et al., 2006).
The study, “Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa
Peru,” was carried out in coordination with the first phase of the MOH’s vector control
program between November 15 and December 8, 2004 (Levy et al., 2006). During the
first round of the campaign, the MOH sprayed 374 houses and peridomestic structures in
Guadalupe using a deltamethrin-based insecticide. Field staff then spent one person-hour
per structure collecting triatomines from individual rooms and animal enclosures, as well
as noting the construction materials of each space. An adult from each household
responded to a survey concerning insecticide usage, cleaning practices, and potential
triatomine infestation (Levy et al., 2006). The data were then examined for two outcome
variables: presence of Triatoma infestans and insect population density, which was
calculated by the number of insects collected in one hour. Each outcome was
independently analyzed for rooms in human and animal structures (Levy et al., 2006).
Triatomine insects were present in both human dwellings and animal enclosures.
In total, 5,398 triatomine insects were captured: 2,270 from households and 3,128 from
animal enclosures or peridomestic structures. Over half (52.0%) of the 374 households in
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the study were infested with triatomines and 72 (19.3%) sheltered T. cruzi-infected
triatomines. Moreover, 107 (13.0%) of the 803 animal enclosures surveyed contained
vectors and 31 (3.9%) were infested with parasite-infected vectors (Levy et al., 2006).
Keeping domestic animals in the yard or on the roof, as a food or income source,
is not uncommon in Guadalupe, and at the time of the survey, 263 (70.0%) of households
raised guinea pigs, dogs, rabbits, chickens, sheep, cats, turkeys, cows, or pigs. In general,
sheep and guinea pigs were kept in adobe and stuccoed structures, respectively, while
chicken-wire pens held rabbits. Data revealed multiple risk factors for triatomine
infestation stemming from these animal enclosures. Chicken-wire pens, for example,
were one-fifth as likely to test positive for triatomine infestation as corrals built partially
or entirely out of adobe or stacked brick, which were significantly more likely to be
infested. In terms of species-specific risk factors, guinea pig enclosures were 1.69 times
more likely to have vectors and were associated with a 2.4-fold increase in triatomine
population density compared to the density found in the enclosures of other pet species.
Furthermore, a guinea-pig pen in a household’s yard further increased the likelihood that
the home would be infested with triatomine insects (Levy et al., 2006).
The risk of triatomine infestation in human dwellings increased for each
additional person sleeping in the room. Indeed, the number of triatomines increased by
42% per additional person per room. Exclusively human-dwelling rooms had 5.2 times
fewer triatomine insects than rooms in which animals—primarily dogs and cats—slept.
Rooms that were fully stuccoed, moreover, had an infestation likelihood of less than onethird, while rooms constructed of brick or sillar—a volcanic stone common to
Arequipa—were 1.6 and 1.8 times more likely, respectively, to house vectors. Based on
the data, the important risk factors for triatomine infestation were: the number of
individuals sleeping in a room, the presence of animals in the same room, and the
materials used to construct the home or animal enclosure. Please refer to the original
article by Levy et al. (2006) for further details. The environmental risk factors identified
by the authors are closely linked to the poverty in the study sites and the numerous other
pueblos jóvenes around Arequipa. In the studies described subsequently, these
relationships continue to resonate.
Chagas Disease Transmission in Periurban Arequipa
Following the finding of parasite-carrying triatomine vectors in periurban
Arequipa, an examination of rates of human infection in these areas ensued. Small studies
in periurban communities in Arequipa have revealed Chagas seroprevalence in children
ranging from 0.7% to 12.9% (Cornejo del Carpio, 2003). On a broader scale, however,
little is known about the epidemiology of the disease in this urban setting. Thus, in order
to determine the prevalence, spatial patterns, and risk factors of Chagas disease, Bowman
et al. conducted a cross-sectional serosurvey in periurban Arequipa. While the main
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target group was school-aged children, they also included a population survey of 1,053
individuals, which allowed for analysis of age-specific prevalence, as well as
examination of how long vector-borne transmission of T. cruzi had been occurring in the
community. Like Levy et al. (2006), “Chagas Disease Transmission in Periurban
Communities of Arequipa, Peru” surveyed residents of Guadalupe but also included
children from the nearby periurban districts of Tiabaya and Sachaca (see Figure 1)
(Bowman et al., 2008).
The data collected during the MOH’s vector control campaign in 2004 and 2005
was used to estimate the proportion of households with both non-infected and T.cruzicarrying triatomines. Based on their geography and demography, the communities were
designated as “hillside shantytowns” (pueblos jóvenes) or “low-lying towns.” Blood
samples were taken from study participants in order to determine seroprevalence for T.
cruzi. Based on the relationship between age and seroprevalence, the authors compared
two different transmission models. In the first model, it was assumed that the probability
of infection increased linearly with the log of an individual’s age rounded to the next
year. The second model hypothesized that the probability of infection increased linearly
with the log of an individual’s age only if the age was greater than the unknown time
since the initiation of transmission in their place of residence (Bowman et al., 2008).
Of the 1,615 children in the serosurvey, 75 or 4.7% had confirmed Chagas
disease. A univariate analysis showed that there was a positive relationship between the
likelihood of individual infection and the proportion of triatomine-infested houses in the
community of residence. A multivariate analysis, moreover, concluded that Chagasinfection risk increased 12% per year of age and that children residing in hillside
shantytowns were more likely to be infected with the disease than those in low-lying
towns. Additionally, the data revealed that Chagas transmission had begun relatively
recently in the community, which confirmed the study’s initial hypothesis that T. cruzi
was introduced into periurban Arequipa within the last two decades. Please refer to the
original article by Bowman et al. (2008) for further details. This study provides evidence
of vector-borne transmission of Chagas disease to persons living in periurban Arequipa
and further describes the differential risk of Chagas in the shantytown setting.
Three years prior to the community-based study, a hospital-based serological
screening study was conducted in puerperal women by Mendoza-Ticona et al. (2005). Of
3,000 women screened for T. cruzi infection in three hospitals and four health centers
around Arequipa, only 0.73% were confirmed seropositive for infection with the parasite.
Higher prevalence was observed in more rural communities near the city of Arequipa.
The authors did not observe any cases of congenital Chagas disease transmission, but
these results were limited by the small sample size of babies born to infected mothers
(Mendoza-Ticona et al, 2005).
Chagas Disease, Migration, and Community Settlement Patterns
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Given that active human contagion of Chagas disease now exists on the outskirts
of Arequipa, it is important to evaluate how the disease vector and parasite may have
arrived to this periurban setting. Since the 1950s, migrants have come to Arequipa
seeking better economic opportunities. Many of these migrants have been from Chagasendemic areas. However, few studies have analyzed the relationship among migration,
settlement patterns, and Chagas disease transmission. In “Chagas Disease, Migration and
Community Settlement Patterns in Arequipa, Peru,” Bayer et al. (2009) conducted a
qualitative study to explore the migration-disease transmission nexus. The study
specifically concentrated on the links between migration, settlement patterns, and
triatomine vector infestation in five peripheral communities (three of which are pueblos
jóvenes).
A total of 94 individuals participated in the study, which consisted of focus
groups and in-depth interviews. Focus groups used participatory methods, such as
community mapping and timeline construction of both general and Chagas-related
events, to explore the participants’ memories of the community demography, migration
patterns, and the historical and current presence of triatomine vectors through activities.
In-depth interviews examined personal stories relating to migration, animal rearing,
Chagas disease, and the presence of triatomine insects. Population data, including the
number of households in the community and insecticide application, was obtained from
the MOH (Bayer et al., 2009).
The data revealed that males migrated more frequently than females with a
median of 4 versus 3 lifetime moves and that most of these moves were among residents
of pueblos jóvenes. Indeed, 80% of participants in these communities had moved to
pueblos jóvenes, whereas 40% of participants from traditional and longer-established
towns were migrants. Subsequent discussion revealed that as the pueblo jóven settlements
grew, the observed number of vectors did as well. The same scenario did not apply to the
traditional towns, however. One of the traditional towns had remained virtually vectorfree despite proximity to highly infested pueblos jóvenes. The other traditional town only
began to experience memorable vector presence about 20 years ago, when its population
became more mobile and new migrants seeking seasonal labor began to arrive (Bayer et
al., 2009).
The superimposition of the MOH data revealed that the pueblos jóvenes had both
several times the population density of the traditional towns and higher proportions of
household infestation by triatomine vectors. For example, the pueblo jóven of Guadalupe
had a population density of 13,061 inhabitants per km2 and a domiciliary infestation
index (DII) of 45.6%, compared to the traditional town of Quequeña, with a population
density of 1,738 and a DII of 19.2% (Bayer et al., 2009).
Despite the higher prevalence of triatomine vectors in pueblos jóvenes, this study
concluded that most of the migrants to these towns did not originally come from T. cruzi-
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endemic areas, and are thus unlikely to have brought the vector or parasite to periurban
Arequipa. Nevertheless, residents of these pueblos jóvenes did make many short- to
medium-term moves to Chagas-endemic areas in search of agricultural work. It is
possible that they were infected during such moves or transported the vector back to their
pueblo jóven in their belongings. Another hypothesis that would explain vector presence
in the pueblos jóvenes—and one that is not mutually exclusive—is that Triatomina
infestans had always been present in the agricultural areas surrounding the city, but the
insect population did not explode until the periurban settlements reached a certain
“critical mass” of human and animal populations. Please refer to the original article by
Bayer et al. (2009) for further details. In its exploration of human migration and
settlement of periurban Arequipa, this study generated several hypotheses to explain how
Chagas disease was introduced to periurban Arequipa, and how the settlement patterns of
the pueblos jóvenes may create especially favorable conditions for the proliferation of
triatomine bugs.
Spatial Patterns and Discordant Diagnostic Test Results
Despite the presence of risk factors like those described in the preceding studies,
diagnosing chronic Chagas disease is often difficult due to the lack of a “gold standard”
test. In order to confirm Chagas, a patient must test positive on two or more serological
tests, which are based on different antigens. Discordance between the two tests occurs in
a certain percentage of results. This discordance is sometimes attributed to the presence
of Leishmania spp. or Trypanosoma rangeli, two other parasites that may cross-react with
Chagas diagnostic tests. Individuals who test positive during the initial screening but
negative during confirmatory testing do not typically receive treatment because their
results are deemed to be false positives due to the inadequacy of the screening test’s
specificity (Levy et al., 2009).
In the article, “Spatial Patterns in Discordant Diagnostic Test Results for Chagas
Disease: Links to Transmission Hotspots,” Levy et al. (2009) examined the relationship
between discordant test results and spatially clustered T. cruzi transmission hotspots. The
authors contended that the spatial information generated from clustered cases of T. cruzi
could be used as a substitute indicator for parasite exposure and thus provide a lens to
evaluate discordant results. The authors hypothesized that if discordant results
represented true Chagas infection and were due to the low sensitivity of confirmatory
tests, they would be more likely to occur among individuals living in areas with high
incidences of confirmed human T. cruzi infection, or so-called “hotspots.” However, if
the discordant results were in fact true negatives, and not a result of low screening test
specificity, they should be randomly distributed relative to the confirmed cases of
Chagas-infected individuals in the community (Levy et al., 2009).
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The subsequent study was also conducted in Guadalupe, a pueblo jóven on the
southwestern margins of Arequipa. Between August and October 2005, a peripheral
blood sample was collected from study participants and screened for antibodies to T.
cruzi. All specimens that were positive at the initial screening were analyzed using two
confirmatory tests. A spatial analysis was then conducted on all discordant confirmatory
test results, and the average distance between the residence of individuals with discordant
results and of those with confirmed Chagas disease was calculated (Levy et al., 2009).
Of the 1,053 participants in the study, 60 (5.7%) had positive results during the
screening phase. Of these 60 individuals, 47 (78.3%) tested positive on both Chagas
confirmatory tests while 13 (21.7%) had discordant confirmatory test results. These 13
participants lived an average of 21.4 meters away from a household with a confirmed
case of Chagas, which is similar to those with consistent results (21.1 meters away). The
results thus revealed that individuals with discordant results were spatially clustered in T.
cruzi “hot spots,” confirming the importance of spatial analysis in Chagas diagnosis, as
well as the further evaluation of discordant test results. Please refer to the original article
by Levy et al. (2009) for further details.
Risk factors associated with Chagas disease in Periurban Arequipa
In their respective investigations into Chagas disease in periurban Arequipa, the
four studies described here identify several distinct risk factors. In general, these factors
can be categorized into two major themes: population dynamics and the urbanization of
poverty.
Population Dynamics
Population dynamics—specifically migration and settlement patterns, population
density, and age—represent a significant risk factor for Chagas transmission.
Population density, both on the community and household level, represents one
risk factor. Bowman et al. (2008) and Levy et al. (2006) confirm that the likelihood of
T.cruzi infection is higher in Arequipa’s highly dense pueblos jóvenes as compared to
less dense communities. Bowman et al. (2008) also note that this phenomenon is
especially true in communities with a greater proportion of vector-infested households.
Thus, campaigns and programs to control triatomine insects are particularly important in
high-density urban areas that continue to attract rural migrants. Based on the evidence in
Bayer et al. (2009), it is particularly crucial to promote vector surveillance of mobile
populations that make frequent moves between communities.
Age, another measure of population dynamics, is also associated with disease
transmission. Bowman et al. (2008) demonstrate that the risk of Chagas infection
increases 12% for every year of age, and thus, older, school-age children and adults
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should regularly be screened for the T. cruzi parasite. This information will not only
improve prognosis for infected individuals, but it will also allow officials to track
transmission over time and increase their understanding of the disease in periurban areas.
Urbanization of Poverty
Residents in periurban communities in Arequipa are generally poorer than those
in the city center and are, therefore, only able to afford inexpensive building materials
that are particularly attractive to triatomine infestation (Levy et al., 2006). Furthermore,
to supplement already meager incomes, many residents’ raise small animals. Such animal
husbandry practices are associated with triatomine vector infestation (Levy et al., 2006;
Bayer et al., 2009). Thus, appearance of Chagas in marginalized periurban Arequipa
underscores the fact that the disease is associated with poverty in general, not just poverty
in rural areas.
Conclusions
As metropolitan Arequipa–and other urban areas in Latin America–continues to
grow, it will be important for public health and medical professionals to use a range of
research methods to investigate the major risk factors associated with Chagas
transmission and monitor how they evolve. Understanding the disease within an urban
context will allow for public health prevention efforts; however, it is important for all of
these initiatives to be undertaken collaboratively by community members and by research
and policy teams and leaders at the district, province, regional, national, and international
levels. The results of the four studies described here underscore several individual
interventions that could be combined to form a multi-pronged prevention approach: (1)
coordinated insecticide application and surveillance of vector reinfestation, particularly in
areas with highly-mobile populations; (2) improvement of building materials used in
houses and peridomestic small animal enclosures; (3) health education for migrant
workers to Chagas-endemic areas; and (4) collection of spatial data on Chagas as a
complement to diagnostic tests.
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